Literature DB >> 1032589

Practical guidelines for assessing patients positive for hepatitis B surface antigen.

S V Feinman, B Berris, J C Sinclair, D W Wrobel.   

Abstract

In assessing the patient the hepatitis B surface antigen (HBsAg) the physician must decide on the basis of physical findings, results of laboratory tests and biopsy, when indicated, whether the patient is an asymptomatic carrier or has acute or chronic hepatitis. Asymptomatic carriers of HBsAg must be educated in personal hygiene and the possibility of transmission, should not be allowed to donate blood or breast-feed and should not work with blood products for human use or pharmaceutical products designated for intravenous use. However, it is otherwise not necessary to advise these individuals to change their profession.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1032589      PMCID: PMC1878866     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  27 in total

1.  A "NEW" ANTIGEN IN LEUKEMIA SERA.

Authors:  B S BLUMBERG; H J ALTER; S VISNICH
Journal:  JAMA       Date:  1965-02-15       Impact factor: 56.272

Review 2.  Chronic active liver disease reexamined: prognosis hopeful.

Authors:  W H Summerskill
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

3.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.

Authors:  J O Nielsen; O Dietrichson; E Juhl
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

4.  Australia antigen in urine.

Authors:  K Apostolov; D J Bauer; J W Selway; R A Fox; F J Dudley; S Sherlock
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

5.  Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis.

Authors:  J O Nielsen; O Dietrichson; P Elling; P Christoffersen
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

6.  Hospital-acquired serum hepatitis. Report of an outbreak.

Authors:  R A Garibaldi; C M Rasmussen; A W Holmes; M B Gregg
Journal:  JAMA       Date:  1972-03-20       Impact factor: 56.272

7.  Vertical transmission of the hepatitis B surface antigen.

Authors:  I L Schweitzer
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

8.  Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state.

Authors:  S V Feinman; N Cooter; J C Sinclair; D M Wobel; B Berris
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

9.  Hepatitis B surface antigen and liver cell carcinoma.

Authors:  A O Williams
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

10.  Passive immunization against viral hepatitis-- status and prospects.

Authors:  G F Grady
Journal:  Am J Med Sci       Date:  1975 Sep-Oct       Impact factor: 2.378

View more
  1 in total

1.  The HBsAg-Positive Patient: Implications and a Guide to Management.

Authors:  R P Larke
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.